Inflammatory mechanisms in patients with chronic obstructive pulmonary disease.

scientific article published on 27 May 2016

Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JACI.2016.05.011
P698PubMed publication ID27373322

P50authorPeter J. BarnesQ7174846
P2093author name stringPeter J Barnes
P2860cites workDecline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1Q36889964
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectchronic obstructive pulmonary diseaseQ199804
inflammationQ101991
P304page(s)16-27
P577publication date2016-05-27
P1433published inThe Journal of Allergy and Clinical ImmunologyQ7743550
P1476titleInflammatory mechanisms in patients with chronic obstructive pulmonary disease
P478volume138

Reverse relations

cites work (P2860)
Q34558199A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.
Q92263764Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension
Q54970130Airway Epithelium Dysfunction in Cystic Fibrosis and COPD.
Q90091260Airway Resistance Caused by Sphingomyelin Synthase 2 Insufficiency in Response to Cigarette Smoke
Q59806270Airway epithelial cells exposed to wildfire smoke extract exhibit dysregulated autophagy and barrier dysfunction consistent with COPD
Q98177065Alteration of immunophenotype of human macrophages and monocytes after exposure to cigarette smoke
Q58585945Alternative Oxidase Attenuates Cigarette Smoke-Induced Lung Dysfunction and Tissue Damage
Q91828468Ambient particulate matter attenuates Sirtuin1 and augments SREBP1-PIR axis to induce human pulmonary fibroblast inflammation: molecular mechanism of microenvironment associated with COPD
Q92218965Analysis of the level of selected parameters of inflammation, circulating immune complexes, and related indicators (neutrophil/lymphocyte, platelet/lymphocyte, CRP/CIC) in patients with obstructive diseases
Q46248584Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis.
Q77790108Association of occupational exposure to disinfectants with incidence of chronic obstructive pulmonary disease among US female nurses
Q39071592Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function
Q42354703Augmenting autophagy for prognosis based intervention of COPD-pathophysiology
Q98735495B-Cell Activating Factor Secreted by Neutrophils Is a Critical Player in Lung Inflammation to Cigarette Smoke Exposure
Q58580329Baicalin Exerts Anti-Airway Inflammation and Anti-Remodelling Effects in Severe Stage Rat Model of Chronic Obstructive Pulmonary Disease
Q64929001Basophils trigger emphysema development in a murine model of COPD through IL-4-mediated generation of MMP-12-producing macrophages.
Q92703279Blockade of EGFR Activation Promotes TNF-Induced Lung Epithelial Cell Apoptosis and Pulmonary Injury
Q50046297Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD.
Q93388171Bronchoalveolar pH and inflammatory biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease
Q47822950Characteristic plethysmographic findings in a guinea pig model of COPD.
Q49733315Cigarette Smoke Exposure Inhibits Bacterial Killing via TFEB-Mediated Autophagy Impairment and Resulting Phagocytosis Defect
Q44591933Cigarette smoke promotes COPD by activating platelet-activating factor receptor and inducing neutrophil autophagic death in mice.
Q92000082Cigarette smoking induces human CCR6+Th17 lymphocytes senescence and VEGF-A secretion
Q97537457Circulating miRNAs as molecular markers of occupational grain dust exposure
Q89735521Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort
Q97537445Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study
Q92149664Clinical significance of BPI-ANCA detecting in COPD patients with Pseudomonas aeruginosa colonization
Q55387022Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.
Q55428223Coronary lesions in patients with COPD (Global Initiative for Obstructive Lung Disease stages I–III) and suspected or confirmed coronary arterial disease.
Q59813607Correlation of serum levels of HIF-1α and IL-19 with the disease progression of COPD: a retrospective study
Q52562729Critical regulation of inflammation via class A scavenger receptor.
Q52327746Crocin attenuates cigarette smoke-induced lung injury and cardiac dysfunction by anti-oxidative effects: the role of Nrf2 antioxidant system in preventing oxidative stress.
Q52726339Defective formyl peptide receptor 2/3 and annexin A1 expressions associated with M2a polarization of blood immune cells in patients with chronic obstructive pulmonary disease.
Q47133214Deficiency of innate-like T lymphocytes in chronic obstructive pulmonary disease
Q99583662Dissociation between airway and systemic autoantibody responses in chronic obstructive pulmonary disease
Q90461041Dysregulation of the Tryptophan Pathway Evidences Gender Differences in COPD
Q91788890Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial
Q93358549Effect of Syringic acid on antioxidant biomarkers and associated inflammatory markers in mice model of asthma
Q38621352Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis
Q96306099Effects of conjugated linoleic acid supplementation on serum levels of interleukin-6 and sirtuin 1 in COPD patients
Q37553291Elastase-Induced Parenchymal Disruption and Airway Hyper Responsiveness in Mouse Precision Cut Lung Slices: Toward an Ex vivo COPD Model
Q96222995Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema
Q61727843Eosinophil-derived IL-13 Promotes Emphysema
Q64259861Epigenetic impacts of maternal tobacco and e-vapour exposure on the offspring lung
Q98772259Epithelial cell-specific loss of function of Miz1 causes a spontaneous COPD-like phenotype and up-regulates Ace2 expression in mice
Q91827939Erythromycin Prevents Elastin Peptide-Induced Emphysema and Modulates CD4+T Cell Responses in Mice
Q64062027Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts
Q37671430Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation.
Q47658841Exercise Inhibits the Effects of Smoke-Induced COPD Involving Modulation of STAT3.
Q64954755Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Q92002839FGF2, an Immunomodulatory Factor in Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Q90699927Fruit and Vegetable Intake and the Risk of Chronic Obstructive Pulmonary Disease: A Dose-Response Meta-Analysis of Observational Studies
Q55070093Function of macrophage scavenger receptor 1 gene polymorphisms in chronic obstructive pulmonary disease with and without lung cancer in China.
Q55981706GOLD 2017 recommendations for COPD patients: toward a more personalized approach
Q94588294GTS-21, an α7nAChR agonist, suppressed the production of key inflammatory mediators by PBMCs that are elevated in COPD patients and associated with impaired lung function
Q90121622Gallic acid protects against the COPD-linked lung inflammation and emphysema in mice
Q37721580HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice
Q40097568Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways
Q90701361Hydrogen gas inhalation protects against cigarette smoke-induced COPD development in mice
Q89905396Hyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary Disease
Q40269947IFN Regulatory Factor 3 Potentiates Emphysematous Aggravation by Lipopolysaccharide
Q37637477IL-10-Producing CD1dhiCD5+ Regulatory B Cells May Play a Critical Role in Modulating Immune Homeostasis in Silicosis Patients
Q91968542IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer
Q64951975IL-33 induces production of autoantibody against autologous respiratory epithelial cells: a potential mechanism for the pathogenesis of COPD.
Q90322419IL10 deficiency promotes alveolar enlargement and lymphoid dysmorphogenesis in the aged murine lung
Q49284188Immune cell response to strenuous resistive breathing: comparison with whole body exercise and the effects of antioxidants
Q38977628Immune-mediated inflammation in the pathogenesis of emphysema: insights from mouse models
Q38848702Impact of chronic kidney disease among Korean adults with chronic obstructive pulmonary disease
Q60921087In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients
Q33812986Inactivation of the Thymidylate Synthase thyA in Non-typeable Haemophilus influenzae Modulates Antibiotic Resistance and Has a Strong Impact on Its Interplay with the Host Airways.
Q41042662Increased Levels of Pro-Inflammatory and Anti-Inflammatory Cellular Responses in Parkinson's Disease Patients: Search for a Disease Indicator.
Q54114455Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
Q91767893Independent factors associate with hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease requiring intensive care unit admission: Focusing on the eosinophil-to-neutrophil ratio
Q53697380Inflammatory and Metabolic Responses to Different Resistance Training on Chronic Obstructive Pulmonary Disease: A Randomized Control Trial.
Q64966018Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases.
Q89882349Integrated transcriptomic correlation network analysis identifies COPD molecular determinants
Q89907088Interleukin-17A Deficiency Attenuated Emphysema and Bone Loss in Mice Exposed to Cigarette Smoke
Q64949368Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers?
Q90396582Jian-Pi-Yi-Fei granule suppresses airway inflammation in mice induced by cigarette smoke condensate and lipopolysaccharide
Q92993366Loss of skin elasticity is associated with pulmonary emphysema, biomarkers of inflammation, and matrix metalloproteinase activity in smokers
Q61447292Loss of the adhesion G-protein coupled receptor ADGRF5 in mice induces airway inflammation and the expression of CCL2 in lung endothelial cells
Q89510732Lung Macrophage Functional Properties in Chronic Obstructive Pulmonary Disease
Q49805694Lung Macrophage Phenotypes and Functional Responses: Role in the Pathogenesis of COPD.
Q59813703Lung Protection Strategies during Cardiopulmonary Bypass Affect the Composition of Blood Electrolytes and Metabolites-A Randomized Controlled Trial
Q55361477Lung cellular senescence is independent of aging in a mouse model of COPD/emphysema.
Q64910929Macrophage function in chronic obstructive pulmonary disease: The many faces of notch signalling.
Q102054047Macrophage metabolic reprogramming during chronic lung disease
Q92352889Macrophages exposed to HIV viral protein disrupt lung epithelial cell integrity and mitochondrial bioenergetics via exosomal microRNA shuttling
Q97521557Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation
Q55517666Microbial and host immune factors as drivers of COPD.
Q49729993Mitochondrial DNA damage and subsequent activation of Z-DNA binding protein 1 links oxidative stress to inflammation in epithelial cells
Q55347367Modulation of Haemophilus influenzae interaction with hydrophobic molecules by the VacJ/MlaA lipoprotein impacts strongly on its interplay with the airways.
Q93126824Molecular Characteristics and Treatment of Endothelial Dysfunction in Patients with COPD: A Review Article
Q38989502Molecular targets of developmental exposure to bisphenol A in diabesity: a focus on endoderm-derived organs.
Q38747579Morning symptoms in COPD: a treatable yet often overlooked factor.
Q97643629NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD
Q64118155New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease
Q92441059Office-Based Sedation/General Anesthesia for COPD Patients, Part II
Q46165199Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease
Q96953110Paraoxonase Activity and Phenotype Distribution in Patients with Chronic Obstructive Pulmonary Disease
Q49865249Pathogenic TH17 inflammation is sustained in the lungs by conventional dendritic cells and Toll-like receptor 4 signaling
Q92798698Peripheral blood CD4+ T cell populations by CD25 and Foxp3 expression as a potential biomarker: reflecting inflammatory activity in chronic obstructive pulmonary disease
Q53440054Physiopathological relationship between chronic obstructive pulmonary disease and insulin resistance.
Q91992623Platelet indices in stable chronic obstructive pulmonary disease - association with inflammatory markers, comorbidities and therapy
Q58804231Precision medicine in COPD: where are we and where do we need to go?
Q90423097Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
Q59126531Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease
Q58584106Protective Effects of Anti-IL17 on Acute Lung Injury Induced by LPS in Mice
Q33603530Pulmonary Extracellular Vesicles as Mediators of Local and Systemic Inflammation
Q64086915RNA-sequencing across three matched tissues reveals shared and tissue-specific gene expression and pathway signatures of COPD
Q64898412Recombinant club cell protein 16 (CC16) ameliorates cigarette smoke‑induced lung inflammation in a murine disease model of COPD.
Q42359679Recuperating lung decoction attenuates inflammation and oxidation in cigarette smoke-induced COPD in rats via activation of ERK and Nrf2 pathways.
Q89717703Relationship between occupational dust exposure levels and mental health symptoms among Korean workers
Q47563688Resveratrol for patients with chronic obstructive pulmonary disease: hype or hope?
Q42379026Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae.
Q55518899Ribosomal Protein S3 Gene Silencing Protects Against Cigarette Smoke-Induced Acute Lung Injury.
Q47159702Role of the inflammasome in chronic obstructive pulmonary disease (COPD).
Q38681962Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases
Q57043148S100A8 Protects Human Primary Alveolar Type II Cells Against Injury and Emphysema
Q54970037SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease.
Q90754511Self-DNA release and STING-dependent sensing drives inflammation to cigarette smoke in mice
Q41632970Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD
Q92059873Serum β2-Microglobulin is Associated with Mortality in Hospitalized Patients with Exacerbated Chronic Obstructive Pulmonary Disease
Q38776298Shifting from Correlation to Causation: Challenges for the Future of Unbiased Molecular Studies in Inflammatory Lung Disease.
Q47664739Soluble guanylate cyclase stimulation reduces oxidative stress in experimental Chronic Obstructive Pulmonary Disease.
Q90526178Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis
Q90135430Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients
Q89876173Systems biology analysis of publicly available transcriptomic data reveals a critical link between AKR1B10 gene expression, smoking and occurrence of lung cancer
Q99614965Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease
Q57712790Targeting transcription factor lysine acetylation in inflammatory airway diseases
Q91632536The Bronchiectasis in COPD-OSA Overlap Syndrome Patients
Q64905994The Notch ligand DNER regulates macrophage IFNγ release in chronic obstructive pulmonary disease.
Q64236830The Role of Autophagy in Eosinophilic Airway Inflammation
Q28077460The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect?
Q59793529The association of elevated circulating endocan levels with lung function decline in COPD patients
Q89688973The bidirectional relationship between chronic obstructive pulmonary disease and coronary artery disease
Q90242330The effects of BAFF on T lymphocytes in chronic obstructive pulmonary disease
Q48193738The long pentraxin PTX3: A prototypical sensor of tissue injury and a regulator of homeostasis
Q91132654The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress
Q38972632Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach
Q90353265Therapeutic potential of BLT1 antagonist for COPD: involvement of inducing autophagy and ameliorating inflammation
Q92656923Therapeutic suppression of pulmonary neutrophilia and allergic airway hyperresponsiveness by a RORγt inverse agonist
Q64102606Transient Receptor Potential Melastatin 8 (TRPM8)-Based Mechanisms Underlie Both the Cold Temperature-Induced Inflammatory Reactions and the Synergistic Effect of Cigarette Smoke in Human Bronchial Epithelial (16HBE) Cells
Q64078726Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status
Q51450105Understanding disease mechanisms at the nanoscale: endothelial apoptosis and microparticles in COPD.
Q64084566Understanding the role of neutrophils in chronic inflammatory airway disease
Q57873240Use of nonhuman primates in obstructive lung disease research – is it required?
Q33703730Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)
Q58605680White blood cell count and all-cause and cause-specific mortality in the Guangzhou biobank cohort study
Q92237314[Research Progress of Treg/Th17 in the Treatment of Chronic Obstructive Pulmonary Disease with Lung Cancer]
Q92366057hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study

Search more.